MD Stock Recent News
MD LATEST HEADLINES
Start Time: 09:00 January 1, 0000 9:26 AM ET Pediatrix Medical Group, Inc. (NYSE:MD ) Q2 2023 Earnings Conference Call August 03, 2023, 09:00 AM ET Company Participants Jim Swift - CEO Marc Richards - EVP and CFO Charles Lynch - SVP, Finance and Strategy Conference Call Participants Pito Chickering - Deutsche Bank Brian Tanquilut - Jefferies Operator Ladies and gentlemen, thank you for standing by. Welcome to the Pediatrix Second Quarter Earnings Conference Call.
The headline numbers for Pediatrix Medical Group (MD) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Pediatrix (MD) reiterates adjusted EBITDA guidance in the range of $235-$245 million for 2023 compared with $241 million in 2022.
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.39 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.47 per share a year ago.
Investors interested in stocks from the Medical Services sector have probably already heard of Pediatrix Medical Group (MD) and Progyny (PGNY). But which of these two stocks offers value investors a better bang for their buck right now?
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2023 Second Quarter Conference Call/Webcast Scheduled for Thursday, August 3, 2023.
Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?
Investors are likely concerned about Pediatrix's (MD) lower enrollment in commercial insurance programs, escalating practice salaries and benefits and net borrowings.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group to Present at 2023 Bank of America Health Care Conference.
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.33 per share a year ago.